Loading…
Dialysis Modalities and HDL Composition and Function
Lipid abnormalities may have an effect on clinical outcomes of patients on dialysis. Recent studies have indicated that HDL dysfunction is a hallmark of ESRD. In this study, we compared HDL composition and metrics of HDL functionality in patients undergoing hemodialysis (HD) or peritoneal dialysis (...
Saved in:
Published in: | Journal of the American Society of Nephrology 2015-09, Vol.26 (9), p.2267-2276 |
---|---|
Main Authors: | , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c390t-553399dd4b46d015bc7632f5d19d9da2240731e77191094d26b58ef9b96408d33 |
---|---|
cites | cdi_FETCH-LOGICAL-c390t-553399dd4b46d015bc7632f5d19d9da2240731e77191094d26b58ef9b96408d33 |
container_end_page | 2276 |
container_issue | 9 |
container_start_page | 2267 |
container_title | Journal of the American Society of Nephrology |
container_volume | 26 |
creator | Holzer, Michael Schilcher, Gernot Curcic, Sanja Trieb, Markus Ljubojevic, Senka Stojakovic, Tatjana Scharnagl, Hubert Kopecky, Chantal M Rosenkranz, Alexander R Heinemann, Akos Marsche, Gunther |
description | Lipid abnormalities may have an effect on clinical outcomes of patients on dialysis. Recent studies have indicated that HDL dysfunction is a hallmark of ESRD. In this study, we compared HDL composition and metrics of HDL functionality in patients undergoing hemodialysis (HD) or peritoneal dialysis (PD) with those in healthy controls. We detected a marked suppression of several metrics of HDL functionality in patients on HD or PD. Compositional analysis revealed that HDL from both dialysis groups shifted toward a more proinflammatory phenotype with profound alterations in the lipid moiety and protein composition. With regard to function, cholesterol efflux and anti-inflammatory and antiapoptotic functions seemed to be more severely suppressed in patients on HD, whereas HDL-associated paraoxonase activity was lowest in patients on PD. Quantification of enzyme activities involved in HDL metabolism suggested that HDL particle maturation and remodeling are altered in patients on HD or PD. In summary, our study provides mechanistic insights into the formation of dysfunctional HDL in patients with ESRD who are on HD or PD. |
doi_str_mv | 10.1681/ASN.2014030309 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4552105</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1708903788</sourcerecordid><originalsourceid>FETCH-LOGICAL-c390t-553399dd4b46d015bc7632f5d19d9da2240731e77191094d26b58ef9b96408d33</originalsourceid><addsrcrecordid>eNpVUD1PwzAUtBCIlsLKiDKypPjb8YJUtZQiFRiA2XJiB4ySuMQJUv89Li0F9Ib3de_e6QA4R3CMeIauJk8PYwwRhSSGPABDxAhJCWXwMNaQ8pRzQQbgJIR3CBHDQhyDAWYiIrAYAjpzuloHF5J7b3TlOmdDohuTLGbLZOrrlQ9x5pvv2bxvik1zCo5KXQV7tssj8DK_eZ4u0uXj7d10skwLImGXsihFSmNoTrmJv_NCcIJLZpA00miMKRQEWSGQRFBSg3nOMlvKXHIKM0PICFxveVd9XltT2KZrdaVWrat1u1ZeO_V_07g39eo_FWUMI8giweWOoPUfvQ2dql0obFXpxvo-KCRgJiERWRah4y20aH0IrS33bxBUG6tVtFr9Wh0PLv6K28N_vCVfsXx4AQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1708903788</pqid></control><display><type>article</type><title>Dialysis Modalities and HDL Composition and Function</title><source>PubMed Central Free</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Holzer, Michael ; Schilcher, Gernot ; Curcic, Sanja ; Trieb, Markus ; Ljubojevic, Senka ; Stojakovic, Tatjana ; Scharnagl, Hubert ; Kopecky, Chantal M ; Rosenkranz, Alexander R ; Heinemann, Akos ; Marsche, Gunther</creator><creatorcontrib>Holzer, Michael ; Schilcher, Gernot ; Curcic, Sanja ; Trieb, Markus ; Ljubojevic, Senka ; Stojakovic, Tatjana ; Scharnagl, Hubert ; Kopecky, Chantal M ; Rosenkranz, Alexander R ; Heinemann, Akos ; Marsche, Gunther</creatorcontrib><description>Lipid abnormalities may have an effect on clinical outcomes of patients on dialysis. Recent studies have indicated that HDL dysfunction is a hallmark of ESRD. In this study, we compared HDL composition and metrics of HDL functionality in patients undergoing hemodialysis (HD) or peritoneal dialysis (PD) with those in healthy controls. We detected a marked suppression of several metrics of HDL functionality in patients on HD or PD. Compositional analysis revealed that HDL from both dialysis groups shifted toward a more proinflammatory phenotype with profound alterations in the lipid moiety and protein composition. With regard to function, cholesterol efflux and anti-inflammatory and antiapoptotic functions seemed to be more severely suppressed in patients on HD, whereas HDL-associated paraoxonase activity was lowest in patients on PD. Quantification of enzyme activities involved in HDL metabolism suggested that HDL particle maturation and remodeling are altered in patients on HD or PD. In summary, our study provides mechanistic insights into the formation of dysfunctional HDL in patients with ESRD who are on HD or PD.</description><identifier>ISSN: 1046-6673</identifier><identifier>EISSN: 1533-3450</identifier><identifier>DOI: 10.1681/ASN.2014030309</identifier><identifier>PMID: 25745027</identifier><language>eng</language><publisher>United States: American Society of Nephrology</publisher><subject>1-Alkyl-2-acetylglycerophosphocholine Esterase - metabolism ; Aged ; Aryldialkylphosphatase - metabolism ; Case-Control Studies ; Cells, Cultured ; Cholesterol - metabolism ; Cholesterol Ester Transfer Proteins - blood ; Clinical Research ; Female ; Humans ; Kidney Failure, Chronic - blood ; Kidney Failure, Chronic - enzymology ; Kidney Failure, Chronic - therapy ; Lipopolysaccharides - pharmacology ; Lipoprotein Lipase - blood ; Lipoproteins, HDL - blood ; Lipoproteins, HDL - chemistry ; Lipoproteins, HDL - pharmacology ; Macrophages - metabolism ; Male ; Middle Aged ; Monocytes - drug effects ; Monocytes - metabolism ; NF-kappa B - metabolism ; Peritoneal Dialysis ; Phosphatidylcholine-Sterol O-Acyltransferase - blood ; Phospholipid Transfer Proteins - blood ; Renal Dialysis - methods ; Triglycerides - blood</subject><ispartof>Journal of the American Society of Nephrology, 2015-09, Vol.26 (9), p.2267-2276</ispartof><rights>Copyright © 2015 by the American Society of Nephrology.</rights><rights>Copyright © 2015 by the American Society of Nephrology 2015</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c390t-553399dd4b46d015bc7632f5d19d9da2240731e77191094d26b58ef9b96408d33</citedby><cites>FETCH-LOGICAL-c390t-553399dd4b46d015bc7632f5d19d9da2240731e77191094d26b58ef9b96408d33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4552105/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4552105/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25745027$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Holzer, Michael</creatorcontrib><creatorcontrib>Schilcher, Gernot</creatorcontrib><creatorcontrib>Curcic, Sanja</creatorcontrib><creatorcontrib>Trieb, Markus</creatorcontrib><creatorcontrib>Ljubojevic, Senka</creatorcontrib><creatorcontrib>Stojakovic, Tatjana</creatorcontrib><creatorcontrib>Scharnagl, Hubert</creatorcontrib><creatorcontrib>Kopecky, Chantal M</creatorcontrib><creatorcontrib>Rosenkranz, Alexander R</creatorcontrib><creatorcontrib>Heinemann, Akos</creatorcontrib><creatorcontrib>Marsche, Gunther</creatorcontrib><title>Dialysis Modalities and HDL Composition and Function</title><title>Journal of the American Society of Nephrology</title><addtitle>J Am Soc Nephrol</addtitle><description>Lipid abnormalities may have an effect on clinical outcomes of patients on dialysis. Recent studies have indicated that HDL dysfunction is a hallmark of ESRD. In this study, we compared HDL composition and metrics of HDL functionality in patients undergoing hemodialysis (HD) or peritoneal dialysis (PD) with those in healthy controls. We detected a marked suppression of several metrics of HDL functionality in patients on HD or PD. Compositional analysis revealed that HDL from both dialysis groups shifted toward a more proinflammatory phenotype with profound alterations in the lipid moiety and protein composition. With regard to function, cholesterol efflux and anti-inflammatory and antiapoptotic functions seemed to be more severely suppressed in patients on HD, whereas HDL-associated paraoxonase activity was lowest in patients on PD. Quantification of enzyme activities involved in HDL metabolism suggested that HDL particle maturation and remodeling are altered in patients on HD or PD. In summary, our study provides mechanistic insights into the formation of dysfunctional HDL in patients with ESRD who are on HD or PD.</description><subject>1-Alkyl-2-acetylglycerophosphocholine Esterase - metabolism</subject><subject>Aged</subject><subject>Aryldialkylphosphatase - metabolism</subject><subject>Case-Control Studies</subject><subject>Cells, Cultured</subject><subject>Cholesterol - metabolism</subject><subject>Cholesterol Ester Transfer Proteins - blood</subject><subject>Clinical Research</subject><subject>Female</subject><subject>Humans</subject><subject>Kidney Failure, Chronic - blood</subject><subject>Kidney Failure, Chronic - enzymology</subject><subject>Kidney Failure, Chronic - therapy</subject><subject>Lipopolysaccharides - pharmacology</subject><subject>Lipoprotein Lipase - blood</subject><subject>Lipoproteins, HDL - blood</subject><subject>Lipoproteins, HDL - chemistry</subject><subject>Lipoproteins, HDL - pharmacology</subject><subject>Macrophages - metabolism</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Monocytes - drug effects</subject><subject>Monocytes - metabolism</subject><subject>NF-kappa B - metabolism</subject><subject>Peritoneal Dialysis</subject><subject>Phosphatidylcholine-Sterol O-Acyltransferase - blood</subject><subject>Phospholipid Transfer Proteins - blood</subject><subject>Renal Dialysis - methods</subject><subject>Triglycerides - blood</subject><issn>1046-6673</issn><issn>1533-3450</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNpVUD1PwzAUtBCIlsLKiDKypPjb8YJUtZQiFRiA2XJiB4ySuMQJUv89Li0F9Ib3de_e6QA4R3CMeIauJk8PYwwRhSSGPABDxAhJCWXwMNaQ8pRzQQbgJIR3CBHDQhyDAWYiIrAYAjpzuloHF5J7b3TlOmdDohuTLGbLZOrrlQ9x5pvv2bxvik1zCo5KXQV7tssj8DK_eZ4u0uXj7d10skwLImGXsihFSmNoTrmJv_NCcIJLZpA00miMKRQEWSGQRFBSg3nOMlvKXHIKM0PICFxveVd9XltT2KZrdaVWrat1u1ZeO_V_07g39eo_FWUMI8giweWOoPUfvQ2dql0obFXpxvo-KCRgJiERWRah4y20aH0IrS33bxBUG6tVtFr9Wh0PLv6K28N_vCVfsXx4AQ</recordid><startdate>20150901</startdate><enddate>20150901</enddate><creator>Holzer, Michael</creator><creator>Schilcher, Gernot</creator><creator>Curcic, Sanja</creator><creator>Trieb, Markus</creator><creator>Ljubojevic, Senka</creator><creator>Stojakovic, Tatjana</creator><creator>Scharnagl, Hubert</creator><creator>Kopecky, Chantal M</creator><creator>Rosenkranz, Alexander R</creator><creator>Heinemann, Akos</creator><creator>Marsche, Gunther</creator><general>American Society of Nephrology</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20150901</creationdate><title>Dialysis Modalities and HDL Composition and Function</title><author>Holzer, Michael ; Schilcher, Gernot ; Curcic, Sanja ; Trieb, Markus ; Ljubojevic, Senka ; Stojakovic, Tatjana ; Scharnagl, Hubert ; Kopecky, Chantal M ; Rosenkranz, Alexander R ; Heinemann, Akos ; Marsche, Gunther</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c390t-553399dd4b46d015bc7632f5d19d9da2240731e77191094d26b58ef9b96408d33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>1-Alkyl-2-acetylglycerophosphocholine Esterase - metabolism</topic><topic>Aged</topic><topic>Aryldialkylphosphatase - metabolism</topic><topic>Case-Control Studies</topic><topic>Cells, Cultured</topic><topic>Cholesterol - metabolism</topic><topic>Cholesterol Ester Transfer Proteins - blood</topic><topic>Clinical Research</topic><topic>Female</topic><topic>Humans</topic><topic>Kidney Failure, Chronic - blood</topic><topic>Kidney Failure, Chronic - enzymology</topic><topic>Kidney Failure, Chronic - therapy</topic><topic>Lipopolysaccharides - pharmacology</topic><topic>Lipoprotein Lipase - blood</topic><topic>Lipoproteins, HDL - blood</topic><topic>Lipoproteins, HDL - chemistry</topic><topic>Lipoproteins, HDL - pharmacology</topic><topic>Macrophages - metabolism</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Monocytes - drug effects</topic><topic>Monocytes - metabolism</topic><topic>NF-kappa B - metabolism</topic><topic>Peritoneal Dialysis</topic><topic>Phosphatidylcholine-Sterol O-Acyltransferase - blood</topic><topic>Phospholipid Transfer Proteins - blood</topic><topic>Renal Dialysis - methods</topic><topic>Triglycerides - blood</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Holzer, Michael</creatorcontrib><creatorcontrib>Schilcher, Gernot</creatorcontrib><creatorcontrib>Curcic, Sanja</creatorcontrib><creatorcontrib>Trieb, Markus</creatorcontrib><creatorcontrib>Ljubojevic, Senka</creatorcontrib><creatorcontrib>Stojakovic, Tatjana</creatorcontrib><creatorcontrib>Scharnagl, Hubert</creatorcontrib><creatorcontrib>Kopecky, Chantal M</creatorcontrib><creatorcontrib>Rosenkranz, Alexander R</creatorcontrib><creatorcontrib>Heinemann, Akos</creatorcontrib><creatorcontrib>Marsche, Gunther</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of the American Society of Nephrology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Holzer, Michael</au><au>Schilcher, Gernot</au><au>Curcic, Sanja</au><au>Trieb, Markus</au><au>Ljubojevic, Senka</au><au>Stojakovic, Tatjana</au><au>Scharnagl, Hubert</au><au>Kopecky, Chantal M</au><au>Rosenkranz, Alexander R</au><au>Heinemann, Akos</au><au>Marsche, Gunther</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dialysis Modalities and HDL Composition and Function</atitle><jtitle>Journal of the American Society of Nephrology</jtitle><addtitle>J Am Soc Nephrol</addtitle><date>2015-09-01</date><risdate>2015</risdate><volume>26</volume><issue>9</issue><spage>2267</spage><epage>2276</epage><pages>2267-2276</pages><issn>1046-6673</issn><eissn>1533-3450</eissn><abstract>Lipid abnormalities may have an effect on clinical outcomes of patients on dialysis. Recent studies have indicated that HDL dysfunction is a hallmark of ESRD. In this study, we compared HDL composition and metrics of HDL functionality in patients undergoing hemodialysis (HD) or peritoneal dialysis (PD) with those in healthy controls. We detected a marked suppression of several metrics of HDL functionality in patients on HD or PD. Compositional analysis revealed that HDL from both dialysis groups shifted toward a more proinflammatory phenotype with profound alterations in the lipid moiety and protein composition. With regard to function, cholesterol efflux and anti-inflammatory and antiapoptotic functions seemed to be more severely suppressed in patients on HD, whereas HDL-associated paraoxonase activity was lowest in patients on PD. Quantification of enzyme activities involved in HDL metabolism suggested that HDL particle maturation and remodeling are altered in patients on HD or PD. In summary, our study provides mechanistic insights into the formation of dysfunctional HDL in patients with ESRD who are on HD or PD.</abstract><cop>United States</cop><pub>American Society of Nephrology</pub><pmid>25745027</pmid><doi>10.1681/ASN.2014030309</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1046-6673 |
ispartof | Journal of the American Society of Nephrology, 2015-09, Vol.26 (9), p.2267-2276 |
issn | 1046-6673 1533-3450 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4552105 |
source | PubMed Central Free; EZB-FREE-00999 freely available EZB journals |
subjects | 1-Alkyl-2-acetylglycerophosphocholine Esterase - metabolism Aged Aryldialkylphosphatase - metabolism Case-Control Studies Cells, Cultured Cholesterol - metabolism Cholesterol Ester Transfer Proteins - blood Clinical Research Female Humans Kidney Failure, Chronic - blood Kidney Failure, Chronic - enzymology Kidney Failure, Chronic - therapy Lipopolysaccharides - pharmacology Lipoprotein Lipase - blood Lipoproteins, HDL - blood Lipoproteins, HDL - chemistry Lipoproteins, HDL - pharmacology Macrophages - metabolism Male Middle Aged Monocytes - drug effects Monocytes - metabolism NF-kappa B - metabolism Peritoneal Dialysis Phosphatidylcholine-Sterol O-Acyltransferase - blood Phospholipid Transfer Proteins - blood Renal Dialysis - methods Triglycerides - blood |
title | Dialysis Modalities and HDL Composition and Function |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T09%3A32%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dialysis%20Modalities%20and%20HDL%20Composition%20and%20Function&rft.jtitle=Journal%20of%20the%20American%20Society%20of%20Nephrology&rft.au=Holzer,%20Michael&rft.date=2015-09-01&rft.volume=26&rft.issue=9&rft.spage=2267&rft.epage=2276&rft.pages=2267-2276&rft.issn=1046-6673&rft.eissn=1533-3450&rft_id=info:doi/10.1681/ASN.2014030309&rft_dat=%3Cproquest_pubme%3E1708903788%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c390t-553399dd4b46d015bc7632f5d19d9da2240731e77191094d26b58ef9b96408d33%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1708903788&rft_id=info:pmid/25745027&rfr_iscdi=true |